Cargando…
2389. Assessing the Time Course of Proton Pump Inhibitor Use and Clostridioides difficile Infection
BACKGROUND: Proton pump inhibitors (PPIs) are a known risk factor for Clostridioides difficile infection (CDI) and recurrence, even in the absence of antibiotic use. No studies have specifically assessed the increased risk for CDI based on PPI duration, given that PPIs are frequently newly prescribe...
Autores principales: | Panagos, Katherine, Blanco, Natalia, Leekha, Surbhi, von Rosenvinge, Erik, Heil, Emily |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810552/ http://dx.doi.org/10.1093/ofid/ofz360.2067 |
Ejemplares similares
-
Impact of a Multi-disciplinary C. difficile Action Team
por: Heil, Emily, et al.
Publicado: (2017) -
2430. Comorbidity and Severity of Illness Risk Adjustment for Hospital-Onset Clostridioides difficile Infection
por: Cabral, Stephanie, et al.
Publicado: (2019) -
2433. Oral Vancomycin Plus Intravenous Metronidazole for Severe Clostridioides difficile Infection in Critically Ill Patients
por: Vega, Ana D, et al.
Publicado: (2019) -
The Proton Pump Inhibitor Omeprazole Does Not Promote Clostridioides difficile Colonization in a Murine Model
por: Tomkovich, Sarah, et al.
Publicado: (2019) -
802. Proton Pump Inhibitors Increase Clostridioides difficile Disease Severity Controlling for Infecting Strains
por: Fallatah, Saad, et al.
Publicado: (2020)